Clincosm LogoSign in Get a demo

gastric cancer

Showing NaN - NaN of 66
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in China (Capecitabine, oxaliplatin, Disitamab Vedotin)

Not yet recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Beijing, Beijing, China
  • +10 more
Nov 23, 2023

Cancer Diagnosis, LungCancer, Gastric Cancer Trial in China

Not yet recruiting
  • Cancer Diagnosis
  • +7 more
    • Guangzhou, Guangdong, China
    • +6 more
    Sep 18, 2023

    Gastric Cancer Response to Neoadjuvant Chemotherapy

    Not yet recruiting
    • Gastric Cancer
    • +2 more
    • Neoadjuvant Chemotherapy
    • Beijing, China
    • +21 more
    Sep 6, 2023

    Gastric Cancer Trial in China (Experimental dose: modified XELOX + sintilimab, Standard dose: standard XELOX + sintilimab)

    Recruiting
    • Gastric Cancer
    • Experimental dose: modified XELOX + sintilimab
    • Standard dose: standard XELOX + sintilimab
    • Guangzhou, Guangdong, China
    • +9 more
    Jun 23, 2023

    Peritoneal Metastasis for Gastric Cancer Based on Radiomics

    Recruiting
    • Gastric Cancer
    • Peritoneal Metastases
    • Peritoneal metastasis status ascertainment
    • Beijing, China
    • +12 more
    Feb 12, 2023

    Advanced Solid Tumor, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Guangzhou, Zhengzhou, Chengdu (CMG901)

    Recruiting
    • Advanced Solid Tumor
    • +3 more
    • Guangzhou, Guangdong, China
    • +31 more
    Dec 26, 2022

    Gut Microbiota of Critical Chronic Diseases in China

    Recruiting
    • Essential Hypertension
    • +10 more
    • no intervention
    • Chaoyang, Beijing, China
    • +49 more
    Dec 16, 2022

    Gastric Cancer Trial (OGT group, Overlap group)

    Recruiting
    • Gastric Cancer
    • OGT group
    • Overlap group
    • Guangzhou, Guangdong, China
      Xinhua Chen
    Nov 2, 2022

    Gastric Cancer, Gastroesophageal Junction Cancer Trial in China (Pembrolizumab, Placebo, Cisplatin)

    Recruiting
    • Gastric Cancer
    • Gastroesophageal Junction Cancer
    • Pembrolizumab
    • +7 more
    • Beijing, Beijing, China
    • +12 more
    Aug 17, 2022

    Solid Tumor, Advanced Cancer, Metastatic Cancer Trial in China, United States (TJ033721)

    Recruiting
    • Solid Tumor
    • +6 more
    • Orange, California
    • +17 more
    Aug 9, 2022

    Gastric Cancer Trial in Guangzhou (DPLDG, LDG)

    Not yet recruiting
    • Gastric Cancer
    • DPLDG
    • LDG
    • Guangzhou, Guangdong, China
      Nanfang Hospital
    Aug 7, 2022

    Gastric Cancer Trial in China, Korea, Republic of, United States (IDX-1197+XELOX, IDX-1197+Irinotecan)

    Recruiting
    • Gastric Cancer
    • Los Angeles, California
    • +11 more
    Aug 7, 2022

    OGT Method Versus the Traditional Overlap Method

    Completed
    • Gastric Cancer
    • The overlap guiding tube(OGT) method
    • The conventional overlap method
    • Guangzhou, Guangdong, China
      Nanfang Hospital
    Jul 1, 2022

    Gastric Cancer, GastroEsophageal Cancer Trial in China (SHR-1210, Capecitabine, Oxaliplatin)

    Completed
    • Gastric Cancer
    • GastroEsophageal Cancer
    • SHR-1210
    • +3 more
    • Hefei, Anhui, China
    • +9 more
    Jun 30, 2022

    Gastric Cancer, Gastroesophageal Junction Cancer Trial in Worldwide (BBI608, Paclitaxel, Placebo)

    Completed
    Has Results
    • Gastric Cancer
    • Gastroesophageal Junction Cancer
    • Scottsdale, Arizona
    • +262 more
    Apr 4, 2022

    The Tumor Microenvironment in Advanced Gastric Cancer

    Recruiting
    • Gastric Cancer
    • non-intervention
    • Guangzhou, Guangdong, China
      Nanfang Hospital, Southern Medical University
    Mar 24, 2022

    Breast Cancer, Gastric Cancer, Gastroesophageal Junction Cancer Trial in China, Korea, Republic of, Taiwan (ZW25, Docetaxel,

    Active, not recruiting
    • Breast Cancer
    • +2 more
    • ZW25
    • +4 more
    • Beijing, Beijing, China
    • +21 more
    Apr 1, 2022

    Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in China (Atezolizumab, Trastuzumab, Capecitabine)

    Recruiting
    • Gastric Cancer
    • Gastroesophageal Junction Adenocarcinoma
    • Beijing, China
    • +9 more
    Mar 11, 2022

    Lung Cancer, Liver Cancer, Colorectal Cancer Trial in Guangzhou (ipilimumab +pembrolizumab +durvalumab)

    Recruiting
    • Lung Cancer
    • +10 more
    • ipilimumab +pembrolizumab +durvalumab
    • Guangzhou, Guangdong, China
      The Second Affiliated Hospital of Guangzhou Medical University
    Jan 10, 2022

    Gastric Cancer, HER2 Overexpressing Gastric Carcinoma Trial in China (RC48-ADC, Paclitaxel injection, Irinotecan Hydrochloride

    Recruiting
    • Gastric Cancer
    • HER2 Overexpressing Gastric Carcinoma
    • Beijing, Beijing, China
    • +51 more
    Jan 6, 2022

    Gastric Cancer Trial in Guangzhou (Carelizumab Combined With Irinotecan and Apatinib)

    Recruiting
    • Gastric Cancer
    • Carelizumab Combined With Irinotecan and Apatinib
    • Guangzhou, Guangdong, China
      NanFang Hospital
    Jun 20, 2021

    Gastric Cancer, Stomach Tumor Trial in China (XELOX or SOX, S001+XELOX or SOX)

    Recruiting
    • Gastric Cancer
    • Stomach Neoplasm
    • XELOX or SOX
    • S001+XELOX or SOX
    • Fuzhou, Fujian, China
    • +8 more
    Jun 18, 2021

    Gastric Cancer Trial in Guangzhou (Docetaxel, Oxaliplatin)

    Recruiting
    • Gastric Cancer
    • Guangzhou, China
      Sixth Affiliated Hospital of Sun Yat-sen University
    May 26, 2021

    Chemo, Gastric Cancer Trial in Guangzhou (FLOT(Docetaxel+oxaliplatin+leucovorin+5-FU), Treprizumab, Tiggio capsule (S-1))

    Recruiting
    • Chemotherapy
    • Gastric Cancer
    • FLOT(Docetaxel+oxaliplatin+leucovorin+5-FU), Treprizumab, Tiggio capsule (S-1)
    • Guangzhou, Guangdong, China
      Guangdong Province Hospital of Chinese Medicine, the Second Affi
    May 10, 2021

    Gastric Cancer Trial in Worldwide (5-Fluorouracil, Capecitabine, Cisplatin)

    Completed
    Has Results
    • Gastric Cancer
    • Fort Myers, Florida
    • +171 more
    Dec 3, 2020